- Home
- ABT vs GS Comparison
ABT vs GS Comparison
Compare ABT & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABT
- GS
- Stock Information
- Founded
- ABT 1888
- GS 1869
- Country
- ABT United States
- GS United States
- Employees
- ABT N/A
- GS N/A
- Industry
- ABT Medical/Dental Instruments
- GS Investment Bankers/Brokers/Service
- Sector
- ABT Health Care
- GS Finance
- Exchange
- ABT Nasdaq
- GS Nasdaq
- Market Cap
- ABT 221.0B
- GS 182.7B
- IPO Year
- ABT N/A
- GS 1999
- Fundamental
- Price
- ABT $132.64
- GS $546.33
- Analyst Decision
- ABT Buy
- GS Buy
- Analyst Count
- ABT 18
- GS 16
- Target Price
- ABT $136.06
- GS $589.29
- AVG Volume (30 Days)
- ABT 7.4M
- GS 3.0M
- Earning Date
- ABT 04-16-2025
- GS 04-14-2025
- Dividend Yield
- ABT 1.78%
- GS 2.20%
- EPS Growth
- ABT 134.36
- GS 77.31
- EPS
- ABT 7.64
- GS 40.54
- Revenue
- ABT $41,950,000,000.00
- GS $52,164,000,000.00
- Revenue This Year
- ABT $6.72
- GS $12.74
- Revenue Next Year
- ABT $7.45
- GS $4.96
- P/E Ratio
- ABT $17.36
- GS $13.47
- Revenue Growth
- ABT 4.59
- GS 15.34
- 52 Week Low
- ABT $99.71
- GS $387.12
- 52 Week High
- ABT $141.23
- GS $672.19
- Technical
- Relative Strength Index (RSI)
- ABT 56.61
- GS 39.31
- Support Level
- ABT $124.50
- GS $551.21
- Resistance Level
- ABT $133.46
- GS $592.64
- Average True Range (ATR)
- ABT 2.67
- GS 15.81
- MACD
- ABT 0.11
- GS 1.73
- Stochastic Oscillator
- ABT 90.85
- GS 36.19
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.